Literature DB >> 12382036

Native valve endocarditis due to Pichia ohmeri.

Isabel João1, José Duarte, Carlos Cotrim, Ana Rodrigues, Cristina Martins, Paula Fazendas, L Moura Oliveira, José Diogo, Manuel Carrageta.   

Abstract

Candida species can cause clinical manifestations in various organs of the cardiovascular system, i.e., the pericardium, myocardium, and endocardium, with endocarditis being the best-known clinical entity. Endocarditis is seen primarily in intravenous drug users and in individuals with damaged native valves, especially in congenital heart disease or rheumatic valvular diseases, and in prosthetic heart valves. The authors present a case of Pichia ohmeri endocarditis in an intravenous drug user, with an unusual presentation form. This is a case of a 42-year-old man, an intravenous heroin user, who was admitted to our Vascular Surgery Department because of fever and acute serious ischemia of the left inferior limb. He presented with fever (39 degrees C), a pale and cold left limb, absence of the left popliteal pulse, and a pansystolic murmur at the cardiac apex. The transthoracic echocardiogram showed a large vegetation on the anterior leaflet of the mitral valve and severe mitral regurgitation with good left ventricular systolic function. Empirical antibiotic therapy was started. Six days after admission, embolectomy was performed with partial clinical recovery. Three blood cultures and the embolus showed a teleomorphic form of Candida guilliermondii - Pichia ohmeri. Therapy with intravenous liposomal amphotericin B, fluocitosin, imipenem, and aztreonam was started. Two weeks later, his clinical condition deteriorated with acute heart failure refractory to medical therapy, mandating mechanical ventilation and high-dose vasopressor and inotropic amine support. He underwent urgent mitral valve replacement with a biologic prosthetic valve. Rapid stabilization of the cardiac status occurred, but ischemic limb lesions required further vascular interventions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12382036     DOI: 10.1007/s003800200034

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  5 in total

Review 1.  Kodamaea ohmeri fungemia in an immunocompetent patient treated with micafungin: case report and review of the literature.

Authors:  Hamid Shaaban; Hoo Feng Choo; Jack Boghossian; George Perez
Journal:  Mycopathologia       Date:  2010-05-07       Impact factor: 2.574

Review 2.  Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review.

Authors:  X Y Han; J J Tarrand; E Escudero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-01-14       Impact factor: 3.267

3.  Kodamaea ohmeri tricuspid valve endocarditis with right ventricular inflow obstruction in a neonate with structurally normal heart.

Authors:  Ponnusamy S Sundaram; Sasidharan Bijulal; Jaganmohan A Tharakan; Molly Antony
Journal:  Ann Pediatr Cardiol       Date:  2011-01

4.  Kodamaea ohmeri fungemia in severe burn: Case study and literature review.

Authors:  Ayaka Tashiro; Takahito Nei; Ryoji Sugimoto; Akiko Watanabe; Jun Hagiwara; Toru Takiguchi; Hiroyuki Yokota; Katsuhiko Kamei
Journal:  Med Mycol Case Rep       Date:  2018-07-20

5.  Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study.

Authors:  Menglan Zhou; Shuying Yu; Timothy Kudinha; Meng Xiao; He Wang; Yingchun Xu; Hongmei Zhao
Journal:  Infect Drug Resist       Date:  2019-06-12       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.